27/07/2025
Congenital heart disease (CHD) is the leading cause of infant morbidity and mortality, with hypoplastic left heart syndrome (HLHS) accounting for up to 9% of CHDs, leading to inadequate systemic circulation after birth.
Second-trimester ultrasound screening and prenatal diagnosis can significantly improve birth outcomes by enabling timely intervention. In a recent case, the Mindray Resona I9 Diagnostic Ultrasound system showcased its cutting-edge precision by detecting an asymmetric four-chamber view of a fetal heart, empowering clinicians to take life-changing action.
Learn more at: https://www.mindray.com/en/media-center/blogs/detection-hypoplastic-left-ventricular-syndrome-second-trimester-screening
